DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Slow-K (Potassium Chloride) - Side Effects and Adverse Reactions

 
 



ADVERSE REACTIONS

One of the most severe adverse effects is hyperkalemia (see CONTRAINDICATIONS, WARNINGS, and OVERDOSAGE). There also have been reports of upper and lower gastrointestinal conditions including obstruction, bleeding, ulceration, and perforation (see CONTRAINDICATIONS and WARNINGS).

      The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. These symptoms are due to irritation of the gastrointestinal tract and are best managed by taking the dose with meals or reducing the amount at one time.

      Skin rash has been reported rarely.



REPORTS OF SUSPECTED SLOW-K SIDE EFFECTS / ADVERSE REACTIONS

Below is a sample of reports where side effects / adverse reactions may be related to Slow-K. The information is not vetted and should not be considered as verified clinical evidence.

Possible Slow-K side effects / adverse reactions in 74 year old male

Reported by a physician from Japan on 2011-10-12

Patient: 74 year old male weighing 55.0 kg (121.0 pounds)

Reactions: Renal Failure, Hyperkalaemia, Diarrhoea, Blood Pressure Decreased, Decreased Appetite

Adverse event resulted in: hospitalization

Suspect drug(s):
Eplerenone
    Indication: Hypokalaemia

Slow-K
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hypokalaemia
    Start date: 2009-02-12
    End date: 2010-03-27

Rasilez
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-11-22
    End date: 2011-05-09

Olmesartan Medoxomil
    Administration route: Oral
    Indication: Hypertension

Other drugs received by patient: Tenormin; Mucosta; Crestor



Possible Slow-K side effects / adverse reactions in 74 year old male

Reported by a physician from Japan on 2011-10-20

Patient: 74 year old male weighing 55.0 kg (121.0 pounds)

Reactions: Hyperkalaemia, Diarrhoea, Blood Pressure Decreased, Decreased Appetite, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Olmesartan Medoxomil
    Dosage: 10 mg,
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-01
    End date: 2011-05-09

Slow-K
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hypokalaemia
    Start date: 2009-02-12
    End date: 2010-03-27

Eplerenone
    Dosage: 100 mg,
    Administration route: Oral
    Indication: Hypokalaemia
    Start date: 2007-11-20
    End date: 2011-05-09

Rasilez
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-11-22
    End date: 2011-05-09

Other drugs received by patient: Crestor; Tenormin; Mucosta



Possible Slow-K side effects / adverse reactions in 74 year old male

Reported by a physician from Japan on 2011-11-02

Patient: 74 year old male weighing 55.0 kg (121.0 pounds)

Reactions: Diarrhoea, Hyperkalaemia, Blood Pressure Decreased, Renal Failure Acute, Decreased Appetite

Adverse event resulted in: hospitalization

Suspect drug(s):
Eplerenone
    Dosage: 100 mg,
    Administration route: Oral
    Indication: Hypokalaemia
    Start date: 2007-11-20
    End date: 2011-05-09

Olmesartan Medoxomil
    Dosage: 10 mg,
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-01
    End date: 2011-05-09

Rasilez
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-11-22
    End date: 2011-05-09

Slow-K
    Dosage: 600 mg
    Administration route: Oral
    Start date: 2010-12-20
    End date: 2011-05-08

Slow-K
    Administration route: Oral
    Indication: Hypokalaemia
    Start date: 2009-02-12
    End date: 2010-03-27

Other drugs received by patient: Mucosta; Crestor; Tenormin



See index of all Slow-K side effect reports >>

Drug label data at the top of this Page last updated: 2006-06-27

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017